GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Current Accrued Expense

Immunoclin (Immunoclin) Current Accrued Expense : $1.32 Mil (As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Current Accrued Expense?

Immunoclin's Current Accrued Expense for the quarter that ended in Oct. 2014 was $1.32 Mil.

Immunoclin's quarterly Current Accrued Expense increased from Apr. 2014 ($0.72 Mil) to Jul. 2014 ($0.99 Mil) and increased from Jul. 2014 ($0.99 Mil) to Oct. 2014 ($1.32 Mil).

Immunoclin's annual Current Accrued Expense stayed the same from Feb. 2012 ($0.00 Mil) to Jan. 2013 ($0.00 Mil) but then increased from Jan. 2013 ($0.00 Mil) to Jan. 2014 ($0.47 Mil).


Immunoclin Current Accrued Expense Historical Data

The historical data trend for Immunoclin's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Current Accrued Expense Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Current Accrued Expense
- - 0.47

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.72 0.99 1.32

Immunoclin Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Immunoclin Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Immunoclin's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunoclin (Immunoclin) Business Description

Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines